Jim Gilbert

Jim Gilbert joined Flagship Pioneering in 2016, bringing to the firm more than 35 years of experience in business strategy for life sciences and healthcare companies. At Flagship, Jim participates in corporate innovation partnerships and investments for the nutritional health sector of the firm. He is also involved with strategic planning and the growth initiatives for the Flagship organization.

Jim began his career at Bain & Company, where he stayed for over 24 years. Based in Boston and Munich, Jim served as the managing director of Bain’s Global Healthcare Practice with a focus on serving medical technology, biopharmaceuticals and life science tools clients. He also held the position of chairman of the management committee, the partner compensation and promotion committee, and the nomination and governance committee. As a leading member of Global Strategy Practice at Bain, Jim was a published author and speaker, sharing insights on medical technology and pharmaceutical industry strategic trends and issues as well as “profit pool-based” and “strategic principled-based” strategy implementation.

After Bain, Jim joined Boston Scientific as group president of the Global Cardiovascular Group and executive vice president of corporate strategy, business development, marketing, and health economics and reimbursement. Among other duties, he was also responsible for providing strategic support on key projects and growth initiatives within Boston Scientific’s broad portfolio.

Most recently, Jim worked as an investor, board member and advisor in the healthcare and life sciences industry. Before joining Flagship in 2016, Jim served as a senior advisor to the investment firm General Atlantic and as a senior operating executive at Welsh, Carson, Anderson & Stowe.

Jim is on the boards of multiple healthcare and life sciences companies, including Flagship portfolio company Sigilon Therapeutics. Jim joined Rubius (NASDAQ: RUBY) as director in 2015 and served as the company’s chairman until mid-2016. He was on the board of directors of Nestlé Health Science between 2012 and 2016. He is also on the board for several other companies, including ECG Management Consultants and National Dentex Corp.

Jim graduated from Cornell University School of Engineering, where he earned a B.S. in industrial engineering and operations research with high distinction, and he holds an M.B.A. with distinction from Harvard Business School.